Orthopediatrics

Orthopediatrics

KIDS· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -23.4% in FY2025

David R. Bailey is the CEO of Orthopediatrics and was paid $3.3M in FY2025 (Dec), down 9%.

Pay$100 in the stock at the end of FY20 → $43
CEO pay is from each Orthopediatrics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1David R. BaileyFY2025
  2. 2Fred L. HiteFY2025
  3. 3Joseph W. HauserFY2025
  4. 4Gregory A. OdleFY2025
  5. 5Daniel J. GerritzenFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Orthopediatrics paid its 5 named executives $10.7M in total in FY2025 (Dec). CEO David R. Bailey was paid $3.3M of that.

Name
David R. BaileyPresident and Chief Executive Officer
Fred L. HiteChief Operating Officer and Chief Financial Officer
Joseph W. HauserPresident of Trauma, Deformity and OPSB
Gregory A. OdlePresident of Scoliosis
Daniel J. GerritzenExecutive Vice President (Legal), General Counsel, and Secretary

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Orthopediatrics. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Board2

See all
  • Bryan W. HughesDirector · 13 yr on the boardIndependentAudit (Chair)—Paid as an executive
  • Kelly FischerDirector · 0 yr on the boardIndependentAudit, Compensation—Paid as an executive

The board of the latest proxy (FY2025).

Activity

  1. PayDEF 14A
  2. Board3
  3. PayDEF 14A
  4. PayDEF 14A
  5. PayDEF 14A
  6. PayDEF 14A
  7. PayDEF 14A
  8. PayDEF 14A
  9. PayDEF 14A
  10. PayDEF 14A
  11. PayDEF 14A
  12. PayDEF 14A
  13. PayDEF 14A
  14. PayDEF 14A
  15. PayDEF 14A
  16. PayDEF 14A
  17. PayDEF 14A

Filings6

See all
Proxy statementDEF 14AApr 20, 2026FY2025
Annual report10-KMar 4, 2026FY2025
Proxy statementDEF 14AApr 2, 2025FY2024
Annual report10-KMar 5, 2025FY2024
Proxy statementDEF 14AApr 8, 2024FY2023
Annual report10-KMar 8, 2024FY2023